Read More
Newsletter Signup | Join Community | Cancer Types
Classification of Non-Hodgkin Lymphomas is necessary to determine treatment.
Cancer Connect
Sep 21, 2018
Treatment of Mantle Cell Lymphoma: ASH 2019 Update: Imbruvica-Rituxan promising - Initial reports on CAR T cell therapy
Apr 1, 2020
Parsaclisib is highly selective PI3Kδ inhibitor precision medicine being developed in refractory B-cell lymphomas
MedMaven
Mar 26, 2020
Understanding Lymphomas: Risks, Causes, Evaluation, Staging and Treatment Planning.
Feb 27, 2020
CA-4948 a novel precision medicine with anti-lymphoma activity an initial report.
Feb 6, 2020
Superior court jury decides NHL was at least partly caused by glyphosate, an ingredient in RoundUp. US EPA Disagrees
Feb 4, 2020
Oct 1, 2018
by
ASH Update: Bispecific antibody immunotherapy appears effective in resistant/refractory NHL.
Dec 8, 2019
Connect with Others at Top Cancer Centers - Second Opinion Options...
TraceyS
Dec 7, 2019
Feb 20, 2020
Williamson
FDA Grants Accelerated Approval to Brukinsa for Mantle Cell Lymphoma
Nov 29, 2019
Mar 20, 2019
How long have people been on watch and wait before they needed treatment ?
Rituxan Maintenance; has your doctor recommended it every 2 or every 3 months?
Oct 19, 2018
Long-Term Follow-Up Indicates Survival with Addition of Rituxan® to CHOP in NHL
Oct 10, 2018
Curious is others with celiac disease have develeoped lymphoma? https://mavendoctors…
